Trial Profile
A study of Hepatic Arterial Infusion of Oxaliplatin plus Fluorouracil/Leucovorin versus Sorafenib for Advanced Hepatocellular Carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2018
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Carcinoma; Liver cancer
- Focus Therapeutic Use
- 27 Feb 2018 New trial record
- 19 Feb 2018 Results published in the Journal of Hepatology